Mechanisms and clinical implications of human gut microbiota-drug interactions in the precision medicine era

S Wang, D Ju, X Zeng - Biomedicines, 2024 - mdpi.com
The human gut microbiota, comprising trillions of microorganisms residing in the
gastrointestinal tract, has emerged as a pivotal player in modulating various aspects of …

Can novel potassium binders liberate people with chronic kidney disease from the low-potassium diet?: A cautionary tale

DE St-Jules, DJ Clegg, BF Palmer… - Clinical Journal of the …, 2022 - journals.lww.com
The advent of new potassium binders provides an important breakthrough in the chronic
management of hyperkalemia for people with CKD. In addition to the direct benefits of …

[HTML][HTML] Campus node-based wastewater surveillance enables COVID-19 case localization and confirms lower SARS-CoV-2 burden relative to the surrounding …

J Lee, N Acosta, BJ Waddell, K Du, K Xiang… - Water Research, 2023 - Elsevier
Wastewater-based surveillance (WBS) has been established as a powerful tool that can
guide health policy at multiple levels of government. However, this approach has not been …

Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management

S Shibata, S Uchida - Therapeutic Apheresis and Dialysis, 2022 - Wiley Online Library
Potassium is a major intracellular cation in the body, regulating membrane potential of
excitable cells, such as cardiomyocytes and skeletal muscle cells. Because the kidney plays …

Clinical efficacy, safety, tolerability, and real-world data of patiromer for the treatment of hyperkalemia

G Colbert, S Sannapaneni… - Drug, Healthcare and …, 2022 - Taylor & Francis
Hyperkalemia remains one of the most difficult consequences of disease state and treatment
for patients with chronic kidney disease, heart failure, and diabetes. Controlling …

[PDF][PDF] Treatment and prevention of hyperkalemia in adults

DB Mount - UpToDate. Waltham (MA): Wolters Kluwer, 2013 - 9thcall.ru
INTRODUCTION—Hyperkalemia is a common clinical problem that is most often a result of
impaired urinary potassium excretion due to acute or chronic kidney disease (CKD) and/or …

[HTML][HTML] Gastrointestinal potassium binding in hemodialysis

BF Palmer, DJ Clegg - Kidney international, 2020 - Elsevier
Hyperkalemia in patients on dialysis is associated with an increased mortality rate. Dietary
restriction is often not effective and deprives patients of heart-healthy foods. Lowering the …

A rare case of patiromer induced hypercalcemia

SR Kanduri, KJ Suchow, JCQ Velez - Journal of Clinical Medicine, 2021 - mdpi.com
Patiromer is a calcium (Ca)-potassium (K) exchange resin approved for the treatment of
hyperkalemia. Disorders of Ca or acid base balance were not reported in pre-approval …

[HTML][HTML] Semaglutide and Patients Receiving Hemodialysis: Case Reports of Unexpected Benefits for Hyperphosphatemia and Hyperkalemia

R Dobson - The Canadian Journal of Hospital Pharmacy, 2024 - pmc.ncbi.nlm.nih.gov
Semaglutide and Patients Receiving Hemodialysis: Case Reports of Unexpected Benefits for
Hyperphosphatemia and Hyperkalemia - PMC Skip to main content Here's how you know …

Gut microbiota and host cometabolism are altered by patiromer-induced changes in serum and stool potassium

B Gao, ES Friedman, R Regunathan… - Kidney International …, 2021 - kireports.org
RESULTS Clinical Parameters This is an ancillary to a parent study that examined the effect
to patiromer treatment on serum and stool electrolytes in HD patients. 6 Characteristics of …